Home
Abbott India Ltd Board of Directors
Board of Directors at Abbott India Ltd
Non Executive Director
Non Executive Director
Independent Director
Non Executive Director
Non Executive Director
Key Highlights
- Munir Shaikh continues to serve as the Chairman (Non-Executive) in 2024, maintaining the same position as in the previous year.
- Kaiyomarz Marfatia continues to serve as the Non Executive Director in 2024, maintaining the same position as in the previous year.
- Ambati Venu continues to serve as the Non Executive Director in 2024, maintaining the same position as in the previous year.
- Anisha Motwani continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
- Sudarshan Jain continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.

Abbott India Ltd
NSE: ABBOTINDIA
Share Price
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 28944.2 |
20 Feb 2025 | 29419.7 |
19 Feb 2025 | 29747.9 |
18 Feb 2025 | 29318.15 |
17 Feb 2025 | 28582.7 |
14 Feb 2025 | 27859.05 |
13 Feb 2025 | 28370.9 |
12 Feb 2025 | 28769.45 |
11 Feb 2025 | 29136.95 |
10 Feb 2025 | 29662.2 |
Company Fundamentals for Abbott India Ltd
Market Cap
61,506 Cr
EPS
628.0
P/E Ratio (TTM)
46.1
P/B Ratio (TTM)
17.5
Day’s High
29301.95
Day’s Low
28725.0
DTE
0.0
ROE
36.5
52 Week High
30683.4
52 Week Low
25200.05
ROCE
48.6
Market Price of Abbott India Ltd
1M
1Y
3Y
5Y
Abbott India Ltd News Hub
Abbott India standalone net profit rises 13.01% in the June 2024 quarter
Net profit of Abbott India rose 13.01% to Rs 328.01 crore in the quarter ended June 2024 as against
Read more
08 Aug 24
Sensex, Nifty hit new life highs; auto shares in demand
The key equity indices further extended gains and hit fresh record highs in mid-morning trade. The N
Read more
20 Sept 24
Abbott India joins hand with Takeda Pharma to launch Vonoprazan tablets in India
Vonoprazan (PCAB or potassium competitive acid blocker) addresses severe acid related disorders like
Read more
20 Sept 24
Abbott India director resigns
Abbott India announced the resignation of Ashok Saini as Commercial Director - GenNext, Vaccines and
Read more
18 Oct 24